Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in moderate to severe alopecia areata
NCT01917058Phase 2Withdrawn
- Sponsor
- Columbia University
- Start
- Aug 2013
- Primary completion
- Aug 2016
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of abatacept in alopecia areata, sponsored by Columbia University. Planned start Aug 2013; status: withdrawn.
02
Drugs
abatacept
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT01917058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01917058.